Fast food chains have had an interesting year with the return of McDonald's dollar menu and America's desire to eat healthier. So what does it mean for the industry going into 2018? Jeff Tomasulo, CEO at Vespula Capital, and Chris Versace, Chief Investment Officer at Tematica Research, join Cheddar to discuss which chain will come out on top.
McDonald's stopped using the value meal strategy in 2013, and it has cost them $2.9 billion in sales, according to Tomasulo. He says the fast food restaurant game is all about volume and getting people in the door. Now that McDonald's brought it back, it's bringing in more foot traffic but also forcing other chains to discount their menus. Wendy's beefed up its "4 for $4" bundles in response to McDonald's dollar menu revival.
Other than price, these fast food chains also need to worry about food safety, something Chipotle has had a rough time with. Versace says if the company can fix the safety issue and get its cost structure in line, the stock could turn for the better in a very quick manner. He says company turnarounds tend to take time and unfortuneatly that shakes investor confidence.
Co-founder and CEO of Colossal Ben Lamm explains how the company is working to bring back extinct species and shares early details of the upcoming documentary from the ‘My Octopus Teacher’ filmmaker.
Soundhound AI co-founder, president, and CEO Keyvan Mojaver discusses bringing its audio tools to cars and drive-thrus, plus why smaller companies may benefit from the A.I. boom.
Deiya Pernas, co-founder of Pernas Research, breaks down Nvidia’s blockbuster earnings, why energy is a sector to watch, and why the A.I. trend is far from over.
The NBA is organizing its next media rights deal to figure out which networks and streaming services will show their games for the next decade. Last time, most of the prominent streaming services didn't exist yet.
Jessica Traver Ingram, CEO and co-founder of IntuiTap Medical, discusses developing the company's Ver Touch device, the crucial FDA approval it just won, and why innovation in spinal blocks and epidurals is long overdue.
